{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:00:46Z","timestamp":1784552446437,"version":"3.55.0"},"reference-count":69,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Cidofovir, an antiviral drug approved for cytomegalovirus retinitis, has emerged as an alternative treatment option for virally induced cutaneous and mucocutaneous conditions, as well as being trialed as a treatment for select neoplasms. In this review, we highlight the existing evidence, clinical uses, and rationale of using cidofovir for the treatment of cutaneous pathologies. Methods: A PubMed database literature search was conducted to identify relevant articles for inclusion in this review. Results: Cidofovir has several cutaneous applications in various formulations including intravenous, topical, and subcutaneous administrations. Primarily through case reports, case series, and retrospective reviews, cidofovir has demonstrated efficacy in treating a variety of virally induced conditions\u2014verruca vulgaris, herpes simplex virus, molluscum contagiosum\u2014as well as in adjuvant treatment for select neoplasms. The drug has shown efficacy in immunocompromised and immunocompetent adults and children alike. Conclusions: The body of literature supports the use of cidofovir as an effective and well-tolerated treatment for many viral cutaneous pathologies, and encourages further study for its use as an adjuvant therapy for neoplastic disease.<\/jats:p>","DOI":"10.3390\/jcm13092462","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T10:34:05Z","timestamp":1713868445000},"page":"2462","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cutaneous Applications of the Antiviral Drug Cidofovir: A Review"],"prefix":"10.3390","volume":"13","author":[{"given":"McKayla","family":"Poppens","sequence":"first","affiliation":[{"name":"David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Ave, Los Angeles, CA 90404, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Ruci","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Ave, Los Angeles, CA 90404, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Davis","sequence":"additional","affiliation":[{"name":"Division of Dermatologic Surgery, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, 2020 Santa Monica Blvd #510, Los Angeles, CA 90404, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,23]]},"reference":[{"key":"ref_1","unstructured":"De Clercq, E. (1996). Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e., herpes-, papova-, pox- and adenovirus) infections. Verh. K. Acad. Geneeskd. Belg., 58."},{"key":"ref_2","first-page":"197","article-title":"Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine","volume":"41","author":"Ho","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"ref_3","first-page":"3","article-title":"A review of topical and intralesional cidofovir","volume":"6","author":"Zabawski","year":"2000","journal-title":"Dermatol. Online J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1525-1470.2008.00689.x","article-title":"Successful treatment of florid cutaneous warts with intravenous cidofovir in an 11-year-old girl","volume":"25","author":"Cusack","year":"2008","journal-title":"Pediatr. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1468-3083.2006.01380.x","article-title":"Intravenous cidofovir treatment for recalcitrant warts in the setting of a patient with myelodysplastic syndrome","volume":"20","author":"Treudler","year":"2006","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_6","first-page":"20499361231165862","article-title":"Intralesional cidofovir for the management of refractory cutaneous verrucae: A review of applications and opportunities","volume":"10","author":"Lau","year":"2023","journal-title":"Ther. Adv. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1017\/S0022215121002322","article-title":"Infantile recurrent respiratory papillomatosis: Review of adjuvant therapies","volume":"135","author":"Patel","year":"2021","journal-title":"J. Laryngol. Otol."},{"key":"ref_8","first-page":"956","article-title":"Use of intralesional cidofovir in the recurrent respiratory papillomatosis: A review of the literature","volume":"24","author":"Gazia","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_9","unstructured":"Gilead Sciences (2010). Vistide (Cidofovir), Gilead Sciences."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1128\/AAC.39.6.1247","article-title":"Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients","volume":"39","author":"Cundy","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0166-3542(97)00022-3","article-title":"Bioavailability and metabolism of cidofovir following topical administration to rabbits","volume":"35","author":"Cundy","year":"1997","journal-title":"Antiviral. Res."},{"key":"ref_12","first-page":"738","article-title":"Pharmacokinetics of cidofovir in monkeys. Evidence for a prolonged elimination phase representing phosphorylated drug","volume":"24","author":"Cundy","year":"1996","journal-title":"Drug Metab. Dispos."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1468-3083.2004.00706.x","article-title":"Topical cidofovir and cryotherapy--combination treatment for recalcitrant molluscum contagiosum in a patient with HIV infection","volume":"18","author":"Baxter","year":"2004","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1001\/archdermatol.2009.363","article-title":"Successful treatment of acyclovir-resistant herpes simplex virus with intralesional cidofovir","volume":"146","author":"Bernardin","year":"2010","journal-title":"Arch. Dermatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2154569","DOI":"10.1080\/09546634.2022.2154569","article-title":"Intralesional cidofovir for the treatment of recalcitrant periungual warts","volume":"34","author":"Poppens","year":"2023","journal-title":"J. Dermatol. Treat."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/(SICI)1096-9071(199807)55:3<215::AID-JMV6>3.0.CO;2-4","article-title":"Treatment of classical Kaposi\u2019s sarcoma with intralesional injections of cidofovir: Report of a case","volume":"55","author":"Simonart","year":"1998","journal-title":"J. Med. Virol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jaad.2020.04.118","article-title":"Intralesional cidofovir for treatment of recalcitrant warts in both immunocompetent and immunocompromised patients: A retrospective analysis of 58 patients","volume":"84","author":"Anshelevich","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/ijd.15210","article-title":"Recalcitrant molluscum contagiosum successfully treated with intralesional cidofovir in a patient with HIV\/AIDS","volume":"60","year":"2021","journal-title":"Int. J. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jaad.2006.01.007","article-title":"Intravenous cidofovir-induced resolution of disfiguring cutaneous human papillomavirus infection","volume":"55","author":"Kottke","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1001\/archderm.140.1.13","article-title":"Intravenous cidofovir for recalcitrant verruca vulgaris in the setting of HIV","volume":"140","author":"Hivnor","year":"2004","journal-title":"Arch. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1046\/j.1468-3083.2000.00184.x","article-title":"Topical cidofovir for severe cutaneous human papillomavirus and molluscum contagiosum infections in patients with HIV\/AIDS. A pilot study","volume":"14","author":"Calista","year":"2000","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/jamadermatol.2013.4014","article-title":"Intralesional cidofovir for treating extensive genital verrucous herpes simplex virus infection","volume":"149","author":"Wanat","year":"2013","journal-title":"JAMA Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00008390-200304000-00016","article-title":"Regression of a cutaneous melanoma metastasis after intralesional cidofovir","volume":"13","author":"Calista","year":"2003","journal-title":"Melanoma Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1136\/bjo.86.8.932","article-title":"Successful treatment of squamous cell carcinoma of the lower eyelid with intralesional cidofovir","volume":"86","author":"Calista","year":"2002","journal-title":"Br. J. Ophthalmol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jdcr.2021.05.001","article-title":"Treatment of acyclovir-resistant herpes simplex virus with intralesional cidofovir","volume":"13","author":"Enescu","year":"2021","journal-title":"JAAD Case Rep."},{"key":"ref_26","first-page":"393","article-title":"Atypical Presentation of Herpes Simplex Virus Type 2 Infection Refractory to Treatment With Aciclovir in 2 Hematologic Patients","volume":"110","year":"2019","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2050313x19847029","DOI":"10.1177\/2050313X19847029","article-title":"A case of an atypical resistant granulomatous HSV-1 and HSV-2 ulceration in an AIDS patient treated with intralesional cidofovir","volume":"7","author":"Saling","year":"2019","journal-title":"SAGE Open Med. Case Rep."},{"key":"ref_28","first-page":"445","article-title":"[Treatment of cutaneous human papilloma virus, poxvirus and herpes simplex virus infections with topical cidofovir in HIV positive patients]","volume":"131","author":"Hirschel","year":"2004","journal-title":"Ann. Dermatol. Venereol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1432-2277.2006.00430.x","article-title":"Local administration of cidofovir for human papilloma virus associated skin lesions in transplant recipients","volume":"20","author":"Bonatti","year":"2007","journal-title":"Transpl. Int."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1177\/120347541201600622","article-title":"Intralesional cidofovir in the treatment of cutaneous warts in a renal transplant patient","volume":"16","author":"Blouin","year":"2012","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1525-1470.2012.01798.x","article-title":"Topical cidofovir for refractory verrucae in children","volume":"30","author":"Gupta","year":"2013","journal-title":"Pediatr. Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.healun.2014.02.012","article-title":"Successful treatment of refractory cutaneous warts using topical 3% cidofovir in a child after heart transplant","volume":"33","author":"Cleary","year":"2014","journal-title":"J. Heart Lung Transplant."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Nickles, M.A., Sergeyenko, A., and Bain, M. (2019). Treatment of warts with topical cidofovir in a pediatric patient. Dermatol. Online J., 25.","DOI":"10.5070\/D3255044063"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/pde.14355","article-title":"Topical cidofovir for the treatment of recalcitrant viral warts and molluscum contagiosum in Jacobsen syndrome","volume":"37","author":"Alsaleemi","year":"2020","journal-title":"Pediatr. Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1067\/mjd.2000.100534","article-title":"Davis MD, Gostout BS, McGovern RM, Persing DH, Schut RL, Pittelkow MR. Large plantar wart caused by human papillomavirus-66 and resolution by topical cidofovir therapy","volume":"43","author":"Davis","year":"2000","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/dth.12061","article-title":"Topical cidofovir for plantar warts","volume":"27","author":"Boz","year":"2014","journal-title":"Dermatol Ther."},{"key":"ref_37","first-page":"663","article-title":"Laser-Assisted Delivery of Topical Cidofovir in the Treatment of Plantar Warts","volume":"18","author":"Coates","year":"2019","journal-title":"J. Drugs Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.jaad.2015.02.1143","article-title":"Intralesional cidofovir for the treatment of a plantar wart","volume":"73","author":"Moore","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1610-0387.2006.05944.x","article-title":"Plantar warts in twins after successful bone marrow transplantation for severe combined immunodeficiency","volume":"4","author":"Marini","year":"2006","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1111\/pde.12992","article-title":"Topical Cidofovir for Recalcitrant Verrucae in Individuals with Severe Combined Immunodeficiency After Hematopoietic Stem Cell Transplantation","volume":"34","author":"Henrickson","year":"2017","journal-title":"Pediatr. Dermatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/dth.12161","article-title":"Successful treatment of periungual warts with topical cidofovir","volume":"27","author":"Boz","year":"2014","journal-title":"Dermatol. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"273","DOI":"10.5021\/ad.2020.32.4.273","article-title":"Cidofovir Intralesional Injection for Recalcitrant Common Warts: A Comparison with Sodium Tetradecyl Sulfate Intralesional Injection","volume":"32","author":"Oh","year":"2020","journal-title":"Ann. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1097\/00002030-199910010-00023","article-title":"Intralesional or topical cidofovir (HPMPC, VISTIDE) for the treatment of recurrent genital warts in HIV-1-infected patients","volume":"13","author":"Orlando","year":"1999","journal-title":"AIDS"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00002030-200202150-00017","article-title":"Combined surgery and cidofovir is an effective treatment for genital warts in HIV-infected patients","volume":"16","author":"Orlando","year":"2002","journal-title":"AIDS"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1177\/1078155219886924","article-title":"Successful treatment of genital warts with cidofovir cream in a pediatric patient with Fanconi anemia","volume":"26","author":"Muffarrej","year":"2020","journal-title":"J. Oncol. Pharm. Pract."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/clinids\/18.4.570","article-title":"Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC)","volume":"18","author":"Snoeck","year":"1994","journal-title":"Clin. Infect. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1001\/archderm.147.12.1462","article-title":"Chronic acyclovir-resistant HSV-2 ulcer in an immunosuppressed patient treated with topical cidofovir","volume":"147","author":"Evans","year":"2011","journal-title":"Arch. Dermatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/1078155212448408","article-title":"Successful clearance of cutaneous acyclovir-resistant, foscarnet-refractory herpes virus lesions with topical cidofovir in an allogeneic hematopoietic stem cell transplant patient","volume":"19","author":"Muluneh","year":"2013","journal-title":"J. Oncol. Pharm. Pract."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1001\/archderm.1997.03890440061010","article-title":"Resolution of recalcitrant molluscum contagiosum virus lesions in human immunodeficiency virus-infected patients treated with cidofovir","volume":"133","author":"Meadows","year":"1997","journal-title":"Arch. Dermatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/S0140-6736(99)01782-1","article-title":"Topical cidofovir for severe molluscum contagiosum","volume":"353","author":"Davies","year":"1999","journal-title":"Lancet"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1046\/j.1525-1470.1999.016005406.7.x","article-title":"Topical cidofovir for molluscum contagiosum in children","volume":"16","author":"Zabawski","year":"1999","journal-title":"Pediatr. Dermatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/000155500750012333","article-title":"Efficacy of cidofovir in the treatment of recalcitrant molluscum contagiosum in an AIDS patient","volume":"80","author":"Ibarra","year":"2000","journal-title":"Acta Derm. Venereol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1001\/archderm.136.8.983","article-title":"Topical cidofovir: A novel treatment for recalcitrant molluscum contagiosum in children infected with human immunodeficiency virus 1","volume":"136","author":"Toro","year":"2000","journal-title":"Arch. Dermatol."},{"key":"ref_54","first-page":"562","article-title":"Topical 1% cidofovir for the treatment of basal cell carcinoma","volume":"12","author":"Calista","year":"2002","journal-title":"Eur. J. Dermatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1365-4632.2008.03772.x","article-title":"Wiskott-Aldrich syndrome and molluscum contagiosum: a therapeutic challenge after reaction to cidofovir","volume":"47","author":"Hicks","year":"2008","journal-title":"Int. J. Dermatol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/archdermatol.2011.20","article-title":"Efficacy of intravenous cidofovir in the treatment of giant molluscum contagiosum in a patient with human immunodeficiency virus","volume":"147","author":"Erickson","year":"2011","journal-title":"Arch. Dermatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.annder.2014.04.114","article-title":"Efficacy and safety of intravenous cidofovir in the treatment of giant molluscum contagiosum in an immunosuppressed patient","volume":"141","author":"Foissac","year":"2014","journal-title":"Ann. Dermatol. Venereol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1046\/j.1365-2133.2002.483111.x","article-title":"Topical cidofovir for erythroplasia of Queyrat of the glans penis","volume":"147","author":"Calista","year":"2002","journal-title":"Br. J. Dermatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2133.2007.08042.x","article-title":"Treatment of lentigo maligna with topical 1% cidofovir","volume":"157","author":"Calista","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"De Clercq, E. (2022). Cidofovir for the Treatment of Molluscum Contagiosum Virus. Viruses, 14.","DOI":"10.3390\/v14112484"},{"key":"ref_61","first-page":"457","article-title":"Disseminated molluscum contagiosum during topical treatment of atopic dermatitis with tacrolimus: Efficacy of cidofovir","volume":"134","author":"Pelletier","year":"2007","journal-title":"Ann. Dermatol. Venereol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e28303","DOI":"10.1002\/jmv.28303","article-title":"Assessment of immunomodulation and regulation of cell cycle in epithelium and stroma after Cidofovir injection in patients with recurrent respiratory papillomatosis-Pilot study","volume":"95","author":"Solarz","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/QAD.0000000000003591","article-title":"Effectiveness of topical cidofovir for treatment of refractory anal high-grade squamous intraepithelial lesion","volume":"37","author":"Burgos","year":"2023","journal-title":"Aids"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"47302","DOI":"10.18632\/oncotarget.10100","article-title":"Cidofovir is active against human papillomavirus positive and negative head and neck and cervical tumor cells by causing DNA damage as one of its working mechanisms","volume":"7","author":"Mertens","year":"2016","journal-title":"Oncotarget"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/jmv.21165","article-title":"Treatment of locally recurrent Epstein-Barr virus-associated nasopharyngeal carcinoma using the anti-viral agent cidofovir","volume":"80","author":"Yoshizaki","year":"2008","journal-title":"J. Med. Virol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcv.2016.07.021","article-title":"The use of brincidofovir for the treatment of mixed dsDNA viral infection","volume":"83","author":"Camargo","year":"2016","journal-title":"J. Clin. Virol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e14173","DOI":"10.1111\/tid.14173","article-title":"Adenovirus infection in allogeneic hematopoietic cell transplantation","volume":"25","author":"Cesaro","year":"2023","journal-title":"Transpl. Infect. Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/tid.12583","article-title":"Brincidofovir treatment of acyclovir-resistant disseminated varicella zoster virus infection in an immunocompromised host","volume":"18","author":"Mullane","year":"2016","journal-title":"Transpl. Infect. Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1177\/00034894211007227","article-title":"Initial Experience Treating HPV-Related Laryngeal Diseases with Oral Brincidofovir: A Pilot Study","volume":"130","author":"Richardson","year":"2021","journal-title":"Ann. Otol. Rhinol. Laryngol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/9\/2462\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:32:49Z","timestamp":1760106769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/9\/2462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,23]]},"references-count":69,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["jcm13092462"],"URL":"https:\/\/doi.org\/10.3390\/jcm13092462","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,23]]}}}